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IL-18 has proinﬂammatory eﬀects and participates in both innate and adaptive cellular and humoral immunity. A number of
SNPs that inﬂuence IL-18 production are found in the gene promoter region. We investigated the association of SNPs in the IL-18
promoter at −607 and −137 with the level of IL-18 protein production by PBMC from healthy donors from Southwestern Siberia.
The genetic distribution of these SNPs in the promoter site was established by PCR. IL-18 protein production was determined by
ELISA.OurresultsshowedthatPBMCfromdonorscarryingallele137ChavelowerlevelsofbothspontaneousandLPS-stimulated
IL-18production.Incontrast,PBMCfromdonorscarryingallele607Ashowedsigniﬁcantincreasesinspontaneousandstimulated
IL-18 production compared to wild type. Our study suggests that the SNPs −607 and −137 in the promoter region of the IL-18
gene inﬂuence the level of IL-18 protein production by PBMC from healthy donors in Southwestern Siberia.
Copyright © 2008 O. P. Khripko et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
IL-18 is a pleiotropic proinﬂammatory cytokine that stim-
ulates production of IFN-γ,T N F - α, IL-1, IL-2, adhesion
molecules and apoptosis factors, increasing T-lymphocyte
proliferation, and enhancing the lytic activity of NK-cells. It
participates in the cellular and humoral immune response
[1], both innate and adaptive [2]. It has been shown that
IL-18 is involved in the pathogenesis of various diseases
including type-I diabetes [3], rheumatoid arthritis [4],
Crohn’s disease [5], and liver cirrhosis [6]. Allelic variants
of cytokine genes associated with promoter gene region
polymorphisms do not inﬂuence the protein amino acid
sequencebutcanresultinchangesincytokineproduction.In
consequence,theymayaltertheimmuneresponsesmediated
by the cytokine in question and could be associated with
various immunological diseases. Three single nucleotide
polymorphisms (SNPs) are found in the IL-18 gene pro-
moter in positions −656 G→T, −607 C→A, and −137
G→C. Two of these, −607 C→Aa n d−137 G→C, are
located at the binding sites for CREB transcriptional factors
(cAMP response-element binding proteins) and the H4TF-
1 nuclear factor, respectively, therefore mutation at these
two sites could inﬂuence IL-18 expression and change the
production of the cytokine [7]. Recent studies have investi-
gated the relationship between IL-18 gene polymorphisms
and predispositions to various diseases. It has been shown
that individuals carrying the −607C −137C haplotype are
prevalent in rheumatoid arthritis cases among the popu-
lations of Germany and Scotland. Women carrying the C-
allele at −137 have a heightened risk of developing ovarian
carcinoma [8]. The presence of such a genotype in patients
with nasopharyngeal carcinoma of an undiﬀerentiated type
worsens the prognosis for the disease and is associated with
earlier metastasis [9] .T h eG - a l l e l ea t−137 is associated with
the development of bronchial asthma and dermal allergic
reactions [10]. In patients with hepatitis B from the Chinese
population, the −137GG and −607CA allele variants of2 Mediators of Inﬂammation
the IL-18 gene promoter are consistently more frequent;
conversely, hepatitis B is encountered consistently more
rarelyinpersonswiththeC-alleleat −137[11].Nevertheless,
the impact of one or other IL-18 allele variant on the level of
protein production has not been adequately studied.
The aim of our study was therefore as follows: to inves-
tigate the distribution of IL-18 allele variants at positions
−607C→Aa n d−137G→C within a population of healthy
donorsfromSouthwesternSiberia,andtheinﬂuenceofthese
allele variants on the level of IL-18 production by their
peripheral blood mononuclear cells (MNCs).
2. MATERIALS AND METHODS
2.1. Objectofresearch
DNA was obtained from PBMC from adult (20–50 years of
age) healthy donors (n = 146) to study polymorphisms in
the promoter region of the IL-18 gene and the production
IL-18 protein. All subjects gave written informed consent
for enrolment in the study, which was approved by the local
Ethics Committee.
2.2. DeﬁnitionofgenotypesIL-18
Genomic DNA was extracted from PBMC by a set Test-NA
(DNA-technology, Russia). Allele-speciﬁc ampliﬁcation was
assessed by ﬂuorescent detection of the products of real-
time PCR. Four primers were used for ampliﬁcation, two
speciﬁc for each polymorphism at positions −607 and −137.
Ampliﬁcation was controled by paired primers speciﬁc to
the particular genomic site. Products were detected using the
intercalating dye SYBR-greenI. PCR was performed using an
iQ4 Cycler (Bio-Rad, USA). The reaction mixture (15μlﬁ n a l
volume) contained 0.3μMs pe c i ﬁ ca n dc o n tr o lp ri m e r s ;P C R
buﬀer (16mM Tris-HCl, pH 8.9, 2.4mM MgCl2,6 5 m M
(NH4)2SO4); 0.2mM dNTP; 1× SYBR-green I; 1 unit Taq-
polymerase; and 5ng DNA. The PCR conditions were as
follows: denaturation (95◦C, 3 minutes) followed by 5 cycles
of ampliﬁcation at 95◦C for 10 seconds, 57◦C for 10 seconds,
and72◦Cfor10seconds;then30cyclesat95◦Cfor3seconds,
59◦C for 3 seconds, 72◦C for 3 seconds, 78◦C for 10 seconds
(plate read), and 82◦C for 10 seconds (plate read). A melting
curve analysis was then performed: 60 cycles starting at
65◦C with temperature increments of 0.5◦C, the plate being
read at each cycle. The data obtained were interpreted on
the basis with the increase in ﬂuorescence, and the melting
curve was used to assess speciﬁcity. The speciﬁc primers used
were
137 C 5 -TAATGTAATATCACTATTTTCATGAAATC-3 
137 G 5 -AATGTAATATCACTATTTTCATGAAATG-3 
607 C 5 -GTTGCAGAAAGTGTAAAAATTATTAC-3 
607 A 5 -GTTGCAGAAAGTGTAAAAATTATTAA-3 .




the reactions in four test tubes simultaneously for each
sample to detect any of the four possible haplotypes.
2.3. PreparationofconditionedmediumfromPBMC
PBMC were isolated from heparinized blood using Ficoll-
Urograﬁn density gradients and were cultured (1 ×
106 cells/mL) for 48 hours in a 48-well plate (Beckton
Dikkinson, USA) in the presence or absence of LPS (055/B5,
Sigma, USA) at a ﬁnal concentration of 10μg/mL.
2.4. DeﬁnitionofIL-18level
The level of IL-18 protein in the conditioned medium was
determined by ELISA (Bender Med Systems, Austria).
2.5. Statisticalanalysis
All SNPs were in Hardy-Weinberg equilibrium in inves-
tigated population.For statistical analysis of the data, we
used the nonparametric Mann-Uitni’s test employing the
Statistica 6.0 program. To identify quantitative diﬀerences in
IL-18 production levels, we used quantile rank classiﬁcation
accordingtotheMosteller-Tewkeealgorithm[12].Toanalyze
the IL-18 concentrations, we determined the probability
limits of the empirical distribution quantiles—(X(qi)). A
number of quantile ranges (K), into which the total ampli-
tude of variation of the IL-18 level was split, were calculated
starting from a minimal sample size (Nmin) by Sturges’s
formula. χ2-criterion (Pχ) and Fisher’s precise method for
small samples (Ptmf) were used to judge the reliability
ofoccurrence for qualitative features and frequencies of
events within diﬀerent ranges of IL-18 variation [13].
3. RESULTS
3.1. IL-18genepromotergenotypedistribution
The distribution of the susceptibility/resistance gene alle-
les responsible for resistance to or risk of developing
immunopathological diseases is unique to each population.
This could be one reason for the diversity of immune
responses to an antigen. This study of two SNPs in the IL-18
genewasconductedonagroupofhealthypersons(n = 146).
The relative frequencies of the C/C, C/A, and A/A variants in
the607C→Apolymorphismwere39.2%,44.7%,and16.1%,
respectively. The C and A alleles occurred at frequencies of
64.5% and 35.5%, respectively. Analysis of the IL-18 gene
polymorphism at the −137→G position gave the following
results: the frequency of the homozygous variant (G/G) was
45.5%, and that of the heterozygous variant G/C was 42.7%;
theC/Cgenotypewasfoundin11.8%ofcases,andtheGand
C allele frequencies were 66.8% and 33.2%, respectively. The
frequenciesoftheAC( −607/−137)haplotypewere22%,AG






















Figure 1: Eﬀect of polymorphic variants in the IL-18 gene
promoter region at −137 G→Co nI L - 1 8p r o t e i np r o d u c t i o nb y
PBMC (data are represented as median and 25 and 75 percentiles)
(↔pMann-Uitni = 0.0494).
3.2. IL-18productionrelatedto
the −607C → Apolymorphism
We next investigated the IL-18 concentration in media
conditioned by the PBMC from healthy donors. The median
levels of IL-18 protein were 21.86pg/mL [9.83; 57.60
(quartiles)] for spontaneous production and 72.44pg/mL
[32.96; 103.07 (quartiles)] for LPS-stimulated production.
WefurtherstudiedthecorrelationbetweenIL-18production
and the polymorphic variants −607C→A in the IL-18 gene
promoter (see Figure 2).
IL-18 production by LPS-stimulated PBMC was signif-
icantly greater in healthy donors carrying the CA genotype
than in those with the CC genotype at the −607 position
of the promoter. We analyzed the relationship between
genotype frequency distributions and IL-18 production,
dividing the cytokine concentrations into “low,” “medium,”
and “high” classes. Concentrations in the 15–85% quantile
range (3.5–93.5pg/mL) for spontaneous production were
classed as “medium.” Production levels outside these limits
were classed as “low” or “high” (see Table 1). We found a
higher frequency of A-allele carriers among persons with a
high level of spontaneous IL-18 production.
3.3. IL-18productionrelatedto
the −137G → Cpolymorphism
We studied the correlation between IL-18 production by
PBMC from healthy donors and variants of the IL-18 geno-
type−137attheposition,andweobtainedthefollowingdata
(see Figure 1).
IL-18 production by LPS-stimulated PBMC was sig-
niﬁcantly less in persons carrying the CC genotype than
in those with the GG genotype at the −137 position. To























Figure 2: Eﬀect of polymorphic variants in the promoter region of
the IL-18 gene at the −607 A→C position on IL-18 production by
PBMC (data are represented as median and 25 and 75 percentiles)
(↔pMann-Uitni = 0.045).
the genotype frequency distribution and levels of IL-18
production. The limits of three primary ranges of variation
in IL-18 production levels were determined by quantile rank
analysis which is tolerant of random statistical “surges” and
critical deviations of a sign from normal distribution. In
accordance with common practice, all empirically obtained
concentrations of this cytokine were classiﬁed as “low,”
“medium,” or “high.” Concentrations in the range 15–85%
(25.6–114.3pg/mL) for LPS-stimulated production were
classed as “medium.” Concentrations outside the limits of
these quantiles, that is, less than 25.6pg/mL and more than
114.3pg/mL, were classed as “low” and “high,” respectively.
We evaluated the allele variant frequencies among pro-
ducers of diﬀerent levels of IL-18. The results are shown in
Table 2.
The frequency of the C allele at the −137 position was
signiﬁcantly higher in donors with low LPS-stimulated IL-18
production than in those with medium or high production.
Thus,LPS-stimulatedproductionofIL-18islowerinpersons
with the CC genotype than in donors with the GG genotype
at the −137 position of the promoter. The C allele frequency




As these two polymorphisms, −137 G/C and −607 C/A,
were in strong linkage disequilibrium [14], all possible
combinations of alleles −607 C→Aa n d−137 G→Ch a v e
been investigated. There has been shown increased sponta-
neous production of IL-18 associated with haplogenotypes
−607CN/−137GN in comparison with −607AA/−137GN
and −607CN/−137CC. Thus alleles −607C and −137G are
associated with increase of spontaneous production of IL-18.4 Mediators of Inﬂammation
Table 1: Distribution of frequencies of IL-18 gene promoter genotypes at the −607 A→C position in relation to the level of spontaneous
IL-18 secretion.
Quantiles of level of spontaneous IL-18 level −607CC −607AN (pemf)p χ2
IL-18 secretion pg/mL nn
Low (0–15%) 0–3.4 7 11 0.2031 >0.1
Medium (15–85%) 3.5–95.3 44 57
High (85–100%) 95.4–138 5 19 0.0239 <0.05
All 56 87
Table 2: Distribution of frequencies of IL-18 gene promoter genotypes at the −137 G→C position in relation to the level of LPS-stimulated
IL-18 secretion.
Quantiles of level of LPS- IL-18 level −137GG −137CN (pemf)p χ2
stimulated IL-18 secretion pg/mL nn
Low (0–15%) 0–25.6 3 14 0.0098 <0.05
Medium (15–85%) 25.7–114.2 48 50
























Figure 3: Capacity to produce IL-18 by mononuclear cells is asso-
ciated with −607/−137 IL-18 polymorphism (data are represented
as median and 25 and 75 percentiles) (↔pMann-Uitni < 0.05).
Increased LPS-stimulated production of IL-18 is associated
withahaplogenotype−607CN/−137GNincomparisonwith
−607CN/−137CC (see Figure 3).
This study showed that the frequencies of IL-18 geno-
types in healthy donors from Novosibirsk city (Southwestern
Siberia) were as follows: −607CC, 32.2%; −607AC, 44.7%;
−607AA, 16.1%; −137GG, 45.5%; −137GC, 42.7%; and
−137CC, 11.8%. For the haplotypes, the values were as
follows: AC (−607/−137), 22%; AG, 14.6%; CG, 55.9%; and
CC, 7.5%. LPS-stimulated production of IL-18 was lower in
persons with the CC genotype than in donors with the GG
genotype at the −137 position of the gene promoter. IL-18
production by LPS-stimulated PBMC from healthy donors
carrying the CA genotype was signiﬁcantly higher than
from those carrying the CC genotype at the −607 position.
Alleles −607C and −137G are associated with increase of
spontaneous production of IL-18, allele −137G increases
spontaneous and stimulated production.
4. DISCUSSION
Geneticfactorsareimportantinthepathogenesisofallmajor
human diseases and it is known that human populations
vary genetically because of polymorphisms, which can
aﬀect aspects of the immune response. Diverse polymorphic
variants of cytokine genes may induce high or low levels
of protein production. Single nucleotide polymorphisms in
the IL-18 gene promoter at −607 C→Aa n d−137 G→C
aﬀect functionally active parts of this promoter, that is,
bindingsitesforCREBtranscriptionalfactorsandtheH4TF-
1 nuclear factor, respectively. Therefore, mutation at these
two sites could inﬂuence IL-18 expression and alter the level
of IL-18 production [7].
Considering the distributions of IL-18 gene alleles in
healthy donors from diﬀerent populations, we found various
frequency rates. In the Japanese population, the genotypes
GG, GC, and CC were found at the −137 position of the
promoter with frequencies of 75.4%, 23.1%, and 1.2%,
respectively; the genotypes AA, AC, and CC at the −607
position had the frequencies 43.9%, 39.2%, and 16.9%,
respectively [15]. Genotype frequencies in the Chinese
population were −137GG, 67.3%; −137GC, 30%; −137CC,
2.7%; −607AA, 24.7%; −607AC, 53.3%; and −607CC, 22%
[11]. For European populations from Switzerland [10]a n d
Italy [9], the characteristic frequencies of the genotypes
−137GG, −137GC, and −137CC were 54.1% and 48.3%,
38.7% and 43.8%, and 7.2% and 7.9%, respectively. IL-18
genotypes at the −607 position of the promoter were found
in the Italian population at the following rates: AA, 23.6%;
AC, 47.2%; CC, 29.2% [9].
We found the following IL-18 genotype frequencies in
healthy donors from Novosibirsk (Southwestern Siberia):
GG, GC, and CC at the −137 position of the promoter wereO. P. Khripko et al. 5
found in 45.5%, 42.7%, and 11.8% of cases, respectively;
AA, AC, and CC at the −607 position were found in
16.1%, 44.7%, and 39.2%, respectively. Thus, the genotype
frequencies within the population of Southwestern Siberia
are similar to those of European countries (Italy and Switzer-
land). There are, however, some diﬀerences in genotype
distribution between the inhabitants of Southwestern Siberia
and the populations of China and Japan.
It is well known that gene promoter polymorphisms
can aﬀect the level of protein production. Our study
demonstrated a relationship between two IL-18 gene pro-
moter polymorphisms and the level of LPS-stimulated IL-
18 production. PBMC from persons carrying the C allele
at the −137 position of the promoter show low LPS-
stimulated production of the cytokine. Also, the level of IL-
18 production by PBMC from donors with the −607AC
genotype is higher than that from donors with the −607CC
g e n o t y p e .T h eAa l l e l ei sl i k e w i s ea s s o c i a t e dw i t hg r e a t e r
LPS-stimulated IL-18 production. There appears little dose
eﬀect of the allele A of −607 SNP and we could not detect
any diﬀerence of IL-18 production when heterozygote for
−137SNPwasconsideredasawhole.However,aftersplitting
heterozygote for one SNP according to their genotype
a to t h e rS N P ,w ew e r ea b l et od e m o n s t r a t ed i ﬀerential
haplogenotypic IL-18 production. The −607CN/−137GN
haplogenotype was associated with a higher spontaneous IL-
18 production. Increased LPS-stimulated production of IL-
18 was associated with a haplogenotype −607CN/−137GN
in comparison with −607CN/−137CC. Thus alleles −607C
and −137G are associated with increase of spontaneous
production of IL-18, allele −137G increases spontaneous
and stimulated production. It is possible to assume that
only in case of presence of both alleles conducts to increase
production of IL-18 protein. The increased frequency of
allele −607A with high production IL-18 is connected with
heterozygotes −607CA (16 donors from 19).
Arimitsu et al. [16] showed that a polymorphic vari-
ant of the IL-18 gene inﬂuenced IL-18 production by
monocytes. In particular, they showed that spontaneous
and LPS-stimulated production of IL-18 in volunteers with
the −137GG genotype was higher than in those with the
−137GC genotype, which is in agreement with our results.
IL-18 is a pleiotropic proinﬂammatory cytokine that
predominantly inﬂuences the diﬀerentiation of type 1 T-
helper cells, thus participating in the establishment of the
cellular immune response and inﬂammatory reactions. IL-
18 has been shown to have antitumor activity. A study of the
relationship between IL-18 gene promoter polymorphisms
andthelikelihoodofdevelopingoncologicaldiseasesshowed
that women carrying the C allele in the −137 position of the
promoter are at greater risk of developing ovarian carcinoma
[8]. On the basis of our results and data from the literature,
one could suppose that the presence of the C allele at the
−137 position in the IL-18 gene promoter in such patients
resultsinalesseﬃcientantitumorimmuneresponsebecause
IL-18 production by immunocompetent cells is diminished.
The serum level of the proinﬂammatory factor IL-
18 is known to be signiﬁcantly elevated in patients with
atopic asthma during the acute phase [17]. Studies of the
association between IL-18 polymorphism and atopic asthma
have revealed that the G allele at the −137 position leads
to an elevated risk of disease development; moreover, none
of the 74 patients examined had the CC genotype [10],
which according to our data is associated with reduced IL-
18 production. Moreover, the linkage disequilibrium was
observed between the −137 and 105 polymorphisms of the
IL-18 gene and the 105A allele of the IL-18 gene which may
be associated with the pathogenesis of asthma [18].
Premature infants with reduced birth weight are at risk
of developing necrotizing enterocolitis and IL-18 that is
also involved in the pathogenesis of this disease. Analysis
of the association between disease severity and genotype
frequencies at the −607 position of the IL-18 gene showed
that the AA genotype frequency is signiﬁcantly higher in
patients with the third and most severe stage of necrotizing
enterocolitis, when the intestinal wall is perforated [19].
On the basis of present knowledge, one may assume that
allelic variants of the IL-18 gene promoter at the −607C→A
and −137G→C positions, which, according to our results,
inﬂuence the level of protein production, could result in
conditions of which the pathogenesis involves a signiﬁcant
role for IL-18.
In conclusion, this study shows that the IL-18 geno-
type frequencies among healthy donors from Novosi-
birsk city (Southwestern Siberia) are as follows: −607CC,
39.2%; −607AC, 44.7%; −607AA, 16.1%; −137GG, 45.5%;
−137GC, 42.7%; and −137CC, 11.8%. This is consistent
with the distributions within European populations (Italy
and Switzerland). Allelic variants in the IL-18 gene promoter
at the −607C→Aa n d−137G→C positions inﬂuence the
level of production of the mediator by immunocompetent
cells. LPS-stimulated production of IL-18 in persons with
the CC genotype is lower than that in donors with the GG
genotype at the −137 position of the promoter. The C allele
frequency is signiﬁcantly higher in the group with low LPS-
stimulated IL-18 production. LPS-stimulated production of
IL-18 by PBMC from healthy donors is signiﬁcantly greater
in those carrying CA genotype at the −607 position. Thus
alleles −607C and −137G are associated with the increase of
spontaneous production of IL-18 and allele −137G increases
spontaneous and stimulated production. It is possible to
assume that only in case of presence of both alleles conducts
to increase production of IL-18 protein.
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